You are here

Vascular & Endovascular


A meta-analysis of five randomized controlled trials found that performing endovascular therapy with stent retrievers was safe and effective in managing acute ischemic stroke and led to a significant improvement in functional clinical outcomes compared with standard therapy.


Recent Headlines

FDA approves combination drug to treat pulmonary arterial hypertension

The FDA approved the combination of ambrisentan and tadalafil to reduce the risks of disease progression and hospitalization for worsening pulmonary arterial hypertension (PAH) and improve exercise ability.

Medtronic agrees to acquire Lazarus Effect to expand its neurovascular business

Medtronic agreed to acquire Lazarus Effect, a medical device company with an acute ischemic stroke product that is approved in Europe but not in the U.S. The deal, which is subject to customary closing conditions, is an all-cash transaction valued at $100 million.

Medtronic acquires Medina Medical to strengthen its neurovascular division

Medtronic acquired Medina Medical, a medical device company developing a device to treat cerebral aneurysms. Medtronic had previously invested and held an ownership stake in Medina Medical, which is based in Menlo Park, Calif.

Cardiologists begin implanting patients with the Watchman device

Hospitals across the U.S. are beginning to implant patients with the Watchman left atrial appendage closure device, which the FDA approved in March.

Working long hours is associated with increased risk of stroke

Employees who work 55 or more hours per week had a higher risk of stroke compared with those who work standard hours, according to a cumulative random-effects meta-analysis of published and unpublished data.

Hospital personnel often overestimate facility performance in delivering stroke care

Fewer than one-third of hospital staff members accurately identified the percentage of patients who received intravenous tissue plasminogen activator (tPA) within 60 minutes of arriving at the institutions, according to an analysis of a national stroke registry. Personnel at low-performing hospitals tended to overestimate their performance in stroke care compared with other hospitals.

Endovascular-first treatment strategy improves outcomes after ruptured AAA

Patients with a ruptured abdominal aortic aneurysm (AAA) who underwent an endovascular-first treatment strategy at Stanford University Medical Center had reductions in perioperative morbidity and mortality and improvements in long-term survival compared with those who had an open repair.

Lower executive function is associated with stroke and CHD risk

Older adults without dementia who had lower executive function had a higher risk of coronary heart disease and stroke, according to an analysis of a prospective, randomized controlled trial.

Benefits don't last when discontinuing warfarin after pulmonary embolism

If patients who experience pulmonary embolism take warfarin for two years, their risk of blood clots and major bleeding are significantly reduced. However, if they stop treatment, the benefits do not last, according to a French multicenter, randomized, double-blind study published this month in JAMA.

Stroke survivors experience long-term cognitive decline

A prospective cohort study found stroke survivors who were at least 45 years old had persistent declines in long-term cognitive functioning over a median follow-up period of more than six years. None of the participants had cognitive impairment at baseline.